Autocrine Transforming Growth Factor α Provides a Growth Advantage to Malignant Cells by Facilitating Re-entry into the Cell Cycle from Suboptimal Growth States
Open Access
- 1 November 1998
- journal article
- Published by Elsevier
- Vol. 273 (47) , 31471-31479
- https://doi.org/10.1074/jbc.273.47.31471
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Modulation of cell cycle control by vitamin D3 and its analogue, EB1089, in human breast cancer cellsOncogene, 1997
- Reduced Expression of Transforming Growth Factor β Type I Receptor Contributes to the Malignancy of Human Colon Carcinoma CellsPublished by Elsevier ,1996
- Reglation of autocrine gastrin expression by the TGFα autocrine loopJournal of Cellular Physiology, 1995
- Growth stimulation by coexpression of transforming growth factor-alpha and epidermal growth factor-receptor in normal and adenomatous human colon epithelium.Journal of Clinical Investigation, 1990
- Intermolecular association of the p185 protein and EGF receptor modulates EGF receptor functionCell, 1990
- Different epidermal growth factor growth responses and receptor levels in human colon carcinoma cell linesCancer Letters, 1988
- Transforming growth factor αCell, 1988
- Expression in rat fibroblasts of a human transforming growth factor-α cDNA results in transformationCell, 1986
- Autocrine Secretion and Malignant Transformation of CellsNew England Journal of Medicine, 1980
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979